Stock Comparison
ARGX vs RPRX
argenx NV ADR and Royalty Pharma Plc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$33.14B
P/E (TTM)
32.7
30.8
Forward P/E
30.4
47.4
Price/Sales
10.0
13.1
Price/Book
6.4
3.7
EV/EBITDA
27.6
33.5
Dividend Yield
—
1.55%
Profitability
Net Margin
30.44%
32.15%
Operating Margin
27.34%
62.34%
Return on Equity
23.60%
14.00%
Return on Assets
11.60%
5.09%
Growth (YoY)
Revenue Growth
59.30%
16.50%
Earnings Growth
95.20%
-46.30%
Price & Risk
Beta
-0.0
0.4
52-Week High
$939.68
$59.97
52-Week Low
$652.43
$34.37
Analyst Target
$1,085.78
$63.75
Compare ARGX and RPRX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.